Stay updated on EPOPEX Follow-up: DBV712 in Young Children Clinical Trial
Sign up to get notified when there's something new on the EPOPEX Follow-up: DBV712 in Young Children Clinical Trial page.

Latest updates to the EPOPEX Follow-up: DBV712 in Young Children Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed study information related to the EPITOPE study and the addition of a new revision number for the product EPOPEX (V712-305).SummaryDifference6%
- Check35 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check78 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference2%
- Check93 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference2%
- Check100 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
Stay in the know with updates to EPOPEX Follow-up: DBV712 in Young Children Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EPOPEX Follow-up: DBV712 in Young Children Clinical Trial page.